Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

Published byΘέκλα Αποστολίδης Modified over 6 years ago

Similar presentations

Presentation on theme: "Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K"— Presentation transcript:

1 Reirradiation of thoracic cancers with intensity modulated proton therapy 
Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K. Allen, PhD, Xiaodong Zhang, PhD, Zhongxing Liao, MD, X. Ronald Zhu, PhD, Daniel Gomez, MD, Steven H. Lin, MD, PhD, Michael Gillin, PhD, Ritsuko Komaki, MD, Stephen Hahn, MD, Joe Y. Chang, MD, PhD  Practical Radiation Oncology  Volume 8, Issue 1, Pages (January 2018) DOI: /j.prro Copyright © 2017 American Society for Radiation Oncology Terms and Conditions

2 Figure 1 A representative plan showing a patient’s (A) previous intensity modulated radiation therapy plan (50 Gy in 25 fractions), (B) reirradiation intensity modulated proton therapy plan (60 Gy in 30 fractions), and (C) composite plan. Practical Radiation Oncology 2018 8, 58-65DOI: ( /j.prro ) Copyright © 2017 American Society for Radiation Oncology Terms and Conditions

3 Figure 2 (A) Freedom from local failure, (B) freedom from locoregional failure, (C), progression-free survival, and (D) overall survival among all patients (solid line), patients who received an equivalent dose in 2-Gy fractions of ≥66 Gy (small dashed line), and patients who received <66 Gy (large dashed line). Practical Radiation Oncology 2018 8, 58-65DOI: ( /j.prro ) Copyright © 2017 American Society for Radiation Oncology Terms and Conditions

Download ppt "Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K"

Similar presentations

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.
Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.
The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.

The evolution of treatment outcomes for resected stage IIIA non–small cell lung cancer over 16 years at a single institution  Linda W. Martin, MD, Arlene.
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.
High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes  Tania Kaprealian, M.D., Vivian Weinberg, Ph.D.,

High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes  Tania Kaprealian, M.D., Vivian Weinberg, Ph.D.,
Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.
Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and.

Hippocampal-sparing and target volume coverage in treating 3 to 10 brain metastases: A comparison of Gamma Knife, single-isocenter VMAT, CyberKnife, and.
Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.
US radiation oncology practice patterns for posttreatment survivor care  Bridget F. Koontz, MD, Rashmi Benda, MD, Jennifer De Los Santos, MD, Karen E.

US radiation oncology practice patterns for posttreatment survivor care  Bridget F. Koontz, MD, Rashmi Benda, MD, Jennifer De Los Santos, MD, Karen E.
Prospective Study of Patient-Reported Symptom Burden in Patients With Non–Small- Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy  Xin.

Prospective Study of Patient-Reported Symptom Burden in Patients With Non–Small- Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy  Xin.
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined- Modality Treatment of Malignant Pleural Mesothelioma  Alexander Chi,

Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined- Modality Treatment of Malignant Pleural Mesothelioma  Alexander Chi,
Postoperative Proton Therapy in the Management of Stage III Thymoma

Postoperative Proton Therapy in the Management of Stage III Thymoma
Andreas Rimner, MD, Daniel R. Gomez, MD, Abraham J

Andreas Rimner, MD, Daniel R. Gomez, MD, Abraham J
Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation 

Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation 
Jonathan A. Abelson, MD, James D. Murphy, MD, MS, Ellen A

Jonathan A. Abelson, MD, James D. Murphy, MD, MS, Ellen A
Safety of differential radiation dosing in lymph node positive necks treated with IMRT  Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,

Safety of differential radiation dosing in lymph node positive necks treated with IMRT  Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,

Similar presentations

Ads by Google